Matthew D. Storck

963 total citations
19 papers, 246 citations indexed

About

Matthew D. Storck is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Matthew D. Storck has authored 19 papers receiving a total of 246 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Hematology. Recurrent topics in Matthew D. Storck's work include Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Cancer Cells and Metastasis (3 papers). Matthew D. Storck is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Cancer Cells and Metastasis (3 papers). Matthew D. Storck collaborates with scholars based in United States, Slovakia and United Kingdom. Matthew D. Storck's co-authors include Hamid Band, Bhopal Mohapatra, Haitao Luan, Wei An, Vimla Band, Vimla Band, Insha Mushtaq, Srikumar M. Raja, Jane L. Meza and Neha Zutshi and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Development.

In The Last Decade

Matthew D. Storck

18 papers receiving 244 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew D. Storck United States 10 151 58 47 33 25 19 246
Pavel Šimara Czechia 12 209 1.4× 54 0.9× 25 0.5× 26 0.8× 41 1.6× 19 318
Eunnyung Bae United States 7 110 0.7× 32 0.6× 54 1.1× 26 0.8× 19 0.8× 7 228
Juan A. Cámara United States 8 249 1.6× 116 2.0× 45 1.0× 64 1.9× 26 1.0× 19 376
Jessica Kalra Canada 11 270 1.8× 88 1.5× 54 1.1× 35 1.1× 23 0.9× 16 404
Norihiro Ishida‐Kitagawa Japan 11 227 1.5× 63 1.1× 46 1.0× 65 2.0× 26 1.0× 19 360
Eiko Hayashi Japan 11 179 1.2× 77 1.3× 32 0.7× 48 1.5× 9 0.4× 22 365
Joanna N. Skhinas Australia 8 139 0.9× 117 2.0× 62 1.3× 34 1.0× 12 0.5× 9 345
Kelly Mitchell United States 10 212 1.4× 67 1.2× 45 1.0× 89 2.7× 18 0.7× 13 379
Elizabeth Murray United Kingdom 6 148 1.0× 37 0.6× 52 1.1× 34 1.0× 32 1.3× 8 265
Timo K. Nykopp Finland 9 154 1.0× 47 0.8× 101 2.1× 19 0.6× 14 0.6× 18 276

Countries citing papers authored by Matthew D. Storck

Since Specialization
Citations

This map shows the geographic impact of Matthew D. Storck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Storck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Storck more than expected).

Fields of papers citing papers by Matthew D. Storck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew D. Storck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Storck. The network helps show where Matthew D. Storck may publish in the future.

Co-authorship network of co-authors of Matthew D. Storck

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew D. Storck. A scholar is included among the top collaborators of Matthew D. Storck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew D. Storck. Matthew D. Storck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Raza, Mohsin Ali, Sameer Mirza, Matthew D. Storck, et al.. (2025). ECD co-operates with ERBB2 to promote tumorigenesis through upregulation of unfolded protein response and glycolysis. Cancer Letters. 632. 217959–217959.
2.
Zutshi, Neha, Bhopal Mohapatra, Wei An, et al.. (2024). Cbl and Cbl-b ubiquitin ligases are essential for intestinal epithelial stem cell maintenance. iScience. 27(6). 109912–109912. 1 indexed citations
3.
Chakraborty, Sukanya, Insha Mushtaq, Haitao Luan, et al.. (2023). EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis. Communications Biology. 6(1). 758–758. 9 indexed citations
4.
Luan, Haitao, Bhopal Mohapatra, Insha Mushtaq, et al.. (2023). EHD2 overexpression promotes tumorigenesis and metastasis in triple-negative breast cancer by regulating store-operated calcium entry. eLife. 12. 8 indexed citations
5.
Luan, Haitao, Robert J. Clubb, Bhopal Mohapatra, et al.. (2021). CHIP/STUB1 Ubiquitin Ligase Functions as a Negative Regulator of ErbB2 by Promoting Its Early Post-Biosynthesis Degradation. Cancers. 13(16). 3936–3936. 9 indexed citations
6.
Luan, Haitao, Bhopal Mohapatra, Insha Mushtaq, et al.. (2018). Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program. Cancer Research. 78(10). 2524–2535. 36 indexed citations
7.
An, Wei, Bhopal Mohapatra, Insha Mushtaq, et al.. (2017). Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene. Journal of Biological Chemistry. 292(9). 3666–3682. 12 indexed citations
8.
Goetz, Benjamin T., Insha Mushtaq, Wei An, et al.. (2017). Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell Function. The Journal of Immunology. 200(2). 483–499. 13 indexed citations
9.
Mohapatra, Bhopal, Neha Zutshi, Wei An, et al.. (2017). An essential role of CBL and CBL-B ubiquitin ligases in mammary stem cell maintenance. Development. 144(6). 1072–1086. 16 indexed citations
10.
Mohapatra, Bhopal, Neha Zutshi, Wei An, et al.. (2017). An essential role of CBL and CBL-B ubiquitin ligases in mammary stem cell maintenance. Journal of Cell Science. 130(7). e1.2–e1.2. 1 indexed citations
11.
Trease, Andrew J., et al.. (2017). EHD4 is a novel regulator of urinary water homeostasis. The FASEB Journal. 31(12). 5217–5233. 3 indexed citations
12.
Raja, Srikumar M., Swapnil S. Desale, Bhopal Mohapatra, et al.. (2016). Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibition. Oncotarget. 7(9). 10522–10535. 26 indexed citations
13.
Bhattacharyya, Sohinee, Mark A. Rainey, Priyanka Arya, et al.. (2016). Endocytic recycling protein EHD1 regulates primary cilia morphogenesis and SHH signaling during neural tube development. Scientific Reports. 6(1). 20727–20727. 31 indexed citations
15.
Huang, Lu, Wei An, Matthew D. Storck, et al.. (2016). CSF-1 receptor signalling is governed by pre-requisite EHD1 mediated receptor display on the macrophage cell surface. Cellular Signalling. 28(9). 1325–1335. 10 indexed citations
16.
An, Wei, Bhopal Mohapatra, Neha Zutshi, et al.. (2016). VAV1-Cre mediated hematopoietic deletion of CBL and CBL-B leads to JMML-like aggressive early-neonatal myeloproliferative disease. Oncotarget. 7(37). 59006–59016. 8 indexed citations
17.
Desale, Swapnil S., Srikumar M. Raja, Jong Oh Kim, et al.. (2015). Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models. Journal of Controlled Release. 208. 59–66. 32 indexed citations
18.
William, Basem M., Wei An, Dan Feng, et al.. (2015). Fasudil, a clinically safe ROCK inhibitor, decreases disease burden in a Cbl/Cbl-b deficiency-driven murine model of myeloproliferative disorders. Hematology. 21(4). 218–224. 4 indexed citations
19.
An, Wei, Bhopal Mohapatra, Neha Zutshi, et al.. (2015). Loss of Cbl and Cbl-b ubiquitin ligases abrogates hematopoietic stem cell quiescence and sensitizes leukemic disease to chemotherapy. Oncotarget. 6(12). 10498–10509. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026